Average Co-Inventor Count = 7.62
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. G.d. Searle & Company (39 from 1,323 patents)
2. Pharmacia Corporation (12 from 200 patents)
3. Confluence Life Sciences, Inc. (7 from 12 patents)
4. Pfizer Corporation (3 from 4,455 patents)
5. Washington University (2 from 1,579 patents)
6. G.d. Searle LLC (2 from 33 patents)
7. Monsanto Company (1 from 3,288 patents)
8. Pharmacia Corporation (of Pfizer, Inc.) (1 from 5 patents)
9. G. D. Dearle & Co. (1 from 1 patent)
10. Aclaris Therapeutics, Inc. (20 patents)
11. Aclaris Life Sciences, Inc. (0 patent)
68 patents:
1. 10815213 - Bruton's tyrosine kinase inhibitors
2. 10266513 - Bruton's tyrosine kinase inhibitors
3. 9505765 - 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment
4. 9365546 - Substituted pyridinone-pyridinyl compounds
5. 9365547 - Substituted pyridinone-pyridinyl compounds
6. 9359300 - Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
7. 9056110 - Substituted pyrimidinone-phenyl-pyrimidinyl compounds
8. 8563558 - Substituted pyridine urea compounds
9. 8507499 - Substituted indole/indazole-pyrimidinyl compounds
10. 7629363 - Diaryl substituted pyridinones
11. 7339078 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12. 7161033 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
13. 7141594 - Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
14. 7138411 - Substituted benzopyran derivatives for the treatment of inflammation
15. 7119098 - Heteroarylakanoic acids as intergrin receptor antagonists